FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/06/069419 [Registered on: 24/06/2024] Trial Registered Prospectively
Last Modified On: 11/06/2024
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Follow Up Study 
Study Design  Other 
Public Title of Study   A Study of Different Categories of Heart Abnormalities in Severe Infection 
Scientific Title of Study   A Study of Cardiac Phenotypes in Sepsis 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Rajika Khanna 
Designation  Junior Resident  
Affiliation  Kasturba Medical College Manipal  
Address  Department of General Medicine, Kasturba Medical College, Madhav Nagar,Manipal
Manipal Academy Of Higher Education,Madhav Nagar,Manipal
Udupi
KARNATAKA
576104
India 
Phone  7022889430  
Fax    
Email  rajikakhanna2309@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Manjunath H Hande 
Designation  Professor 
Affiliation  Kasturba Medical College Manipal  
Address  Department of General Medicine, Kasturba Medical College, Madhav Nagar, Manipal, Karnataka, India
Manipal Academy Of Higher Education,Madhav Nagar,Manipal
Udupi
KARNATAKA
576104
India 
Phone  9972597655  
Fax    
Email  manjunath.hande@manipal.edu  
 
Details of Contact Person
Public Query
 
Name  Dr Manjunath H Hande 
Designation  Professor 
Affiliation  Kasturba Medical College Manipal  
Address  Department of General Medicine, Kasturba Medical College, Madhav Nagar,Manipal
Manipal Academy Of Higher Education,Madhav Nagar,Manipal
Udupi
KARNATAKA
576104
India 
Phone  9972597655  
Fax    
Email  manjunath.hande@manipal.edu  
 
Source of Monetary or Material Support  
Department Of General Medicine,Kasturba Medical College,Madhav Nagar, Manipal,Karnataka,India,Pin code-576104 
 
Primary Sponsor  
Name  Katurba Medical College Manipal 
Address  Kasturba Medical College,Madhav Nagar,Manipal,Karnataka,India,Pin Code-576104 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Rajika Khanna  Kasturba Medical College Manipal  Department of General Medicine,Madhav Nagar,Manipal,Karnataka,India,Pin Code-576104
Udupi
KARNATAKA 
7022889430

rajikakhanna2309@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Kasturba Medical College and Kasturba hospital institutional Ethics Committe - Student Research  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: A00-B99||Certain infectious and parasitic diseases, (2) ICD-10 Condition: I00-I99||Diseases of the circulatory system,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  NIL  NIL 
Comparator Agent  NIL  NIL 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  99.00 Year(s)
Gender  Both 
Details  Patients diagnosed to have sepsis by sepsis 3 guidelines and seeking treatment for the same at kasturba Medical College under General Medicine Department. 
 
ExclusionCriteria 
Details  Pre-existing Valvular Heart Disease/ Pre-existing Congenital Heart Disease/ Pregnancy/ Atrial Fibrillation/Cardiac arrest within 48 hours of presentation/ Ascites/ Pneumothorax 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
To determine the prevalence of various cardiac manifestations in patients diagnosed as sepsis in order to understand specific treatment provided depending on cardiac outcomes.   24 hours,28 days 
 
Secondary Outcome  
Outcome  TimePoints 
To draw comparison between various cardiac phenotypes through deranged
clinical parameters,prognosis and mortality rates. 
24 hours 28 day 
 
Target Sample Size   Total Sample Size="112"
Sample Size from India="112" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   10/07/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="9"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   The proposed study involves obtaining ethical clearance and informed consent before conducting a prospective, longitudinal investigation into sepsis among ICU patients. It will recruit patients diagnosed with sepsis using the SOFA score, focusing on those admitted under general medicine. Data collection will include medical history, laboratory results, and clinical assessments. Echocardiography within 24 hours of admission will evaluate cardiac function, with particular attention to indicators of distributive or hypodynamic shock. RV dysfunction will be assessed using TAPSE, and the IVC diameter will be measured. Patient safety and confidentiality will be paramount throughout the study. Follow-up will continue for 28 days post-admission to monitor patient outcomes. 
Close